Latest News
AstraZeneca shares fall on report of potential China probe fallout
Reuters - Tue Nov 5, 2:14PM CST
Reuters
Tue Nov 5, 2:14PM CST
The Anglo-Swedish company, which has invested heavily in the worldโs No. 2 pharmaceuticals market, said last week that its China president, Leon Wang, was under investigation and that the drugmaker would cooperate with authorities
3 Magnificent Stocks Under $100 to Buy in November
Motley Fool - Sun Nov 3, 5:41AM CST
Motley Fool
Sun Nov 3, 5:41AM CST
The price could be right for these stocks.
3 Rock-Solid Dividend Stocks You Can Buy and Hold Forever
Motley Fool - Thu Oct 31, 6:00AM CDT
Motley Fool
Thu Oct 31, 6:00AM CDT
In a frothy market starved for value, these three dividend stocks combine reasonable valuations with the proven ability to disrupt themselves.
1 'Strong Buy' Penny Stock to Invest in AI Drug Development
Barchart - Wed Oct 9, 8:21AM CDT
Barchart
Wed Oct 9, 8:21AM CDT
Investors seeking AI-led drug development opportunities can consider this top-rated biotech stock under $5.
Want to Invest in the Weight Loss Boom? Consider Buying These 2 Stocks
Motley Fool - Tue Oct 8, 5:30AM CDT
Motley Fool
Tue Oct 8, 5:30AM CDT
Investing in the most popular players in the space isn't the only valid approach.
Stock Market Analysis & News: October 7th, 2024
Stock Target Advisor - Mon Oct 7, 12:02PM CDT
Stock Target Advisor
Mon Oct 7, 12:02PM CDT
Global Markets Canadian Markets Canadaโs main stock index, the TSX experienced a slight decline on Monday as investors reassessed expectations for a potential interest rate cut by the Federal Reserve in November, and its impact on Canadian financial markets and the Bank of Canadaโs future rate policy settings . This...
Is Summit Therapeutics Stock a Buy?
Motley Fool - Mon Sep 30, 5:28AM CDT
Motley Fool
Mon Sep 30, 5:28AM CDT
Its alliance with a successful foreign biotech could be decisive for the stock.
2 Unstoppable S&P 500 Dividend Stocks to Buy Before They Beat the Market Again
Motley Fool - Thu Sep 19, 3:21AM CDT
Motley Fool
Thu Sep 19, 3:21AM CDT
For over a decade, these two drugmakers consistently outperformed the benchmark index and could do it again.
Targeting Cancer's Achilles Heel: AI-Driven DDR Therapies Offer Hope
AllPennyStocks.com - Tue Sep 17, 4:04PM CDT
AllPennyStocks.com
Tue Sep 17, 4:04PM CDT
Cancer, a complex disease characterized by uncontrolled cell growth and proliferation, is often rooted in defects within DNA repair mechanisms. Normally, cells possess intricate repair pathways that rectify mutations or damage caused by environmental factors or internal processes. However, when these pathways malfunction, either due to genetics or acquired mutations,...
Junior Biotech Utilizes AI To Shorten Drug Discovery Timelines, Ultimately Saving Lives
Yolowire - Tue Sep 10, 5:39PM CDT
Yolowire
Tue Sep 10, 5:39PM CDT
The urgent need for innovative technologies to accelerate the development of life-saving %Cancer therapies has never been more critical. With millions of lives and billions of dollars at stake, the potential to shorten drug development timelines...
Junior Biotech Utilizes AI To Shorten Drug Discovery Timelines, Ultimately Saving Lives
AllPennyStocks.com - Tue Sep 10, 5:22PM CDT
AllPennyStocks.com
Tue Sep 10, 5:22PM CDT
The urgent need for innovative technologies to accelerate the development of life-saving cancer therapies has never been more critical. With millions of lives and billions of dollars at stake, the potential to shorten drug development timelines is paramount. DNA-damage response (DDR)-based therapies, which target cancer cells' repair mechanisms, are emerging...
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing
Newswire.ca - Tue Sep 10, 9:16AM CDT
Newswire.ca
Tue Sep 10, 9:16AM CDT
/CNW/ -- SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced a new...
AstraZenecaโs Stock Falls 5% As Cancer Drug Trial Disappoints
Baystreet - Tue Sep 10, 9:00AM CDT
Baystreet
Tue Sep 10, 9:00AM CDT
Shares of AstraZeneca (AZN) are down 5% after the British pharmaceutical company reported disappointing ...
3 Market-Beating Stocks to Buy for Less Than $100
Motley Fool - Fri Sep 6, 4:15AM CDT
Motley Fool
Fri Sep 6, 4:15AM CDT
These stocks are all up more than 20% this year.
As Radiotherapy Redefines Cancer Care, Here's the Stock to Buy Near 52-Week Highs
Barchart - Wed Aug 14, 2:12PM CDT
Barchart
Wed Aug 14, 2:12PM CDT
A new generation of radiotherapies are redefining cancer care, offering the potential for a more powerful treatment with fewer side effects. It could become a mainstream therapy for the big "traditional" cancers that make the disease the leading cause of death worldwide, which is why Morgan Stanley forecast the radiopharma market will be worth $39B in sales by 2032.
Here's What AstraZeneca's CEO Has to Say About the Weight Loss Drugs Market
Motley Fool - Sun Aug 4, 9:07AM CDT
Motley Fool
Sun Aug 4, 9:07AM CDT
The winners of today might not compete in the lucrative new segment of tomorrow.
3 Surprisingly Underrated Stocks to Buy Right Now
Motley Fool - Fri Jul 26, 11:25AM CDT
Motley Fool
Fri Jul 26, 11:25AM CDT
These stocks arguably deserve more respect from investors.
Why AstraZeneca Stock Is Sliding Today
Motley Fool - Thu Jul 25, 10:48AM CDT
Motley Fool
Thu Jul 25, 10:48AM CDT
The British drugmaker's Q2 results were good, but seemingly not good enough for many investors.
AstraZeneca Plc (AZN) Q2 2024 Earnings Call Transcript
Motley Fool - Thu Jul 25, 10:45AM CDT
Motley Fool
Thu Jul 25, 10:45AM CDT
AZN earnings call for the period ending June 30, 2024.
AstraZeneca raises profit outlook on strong medicines demand
Reuters - Thu Jul 25, 5:53AM CDT
Reuters
Thu Jul 25, 5:53AM CDT
Second-quarter profit was dented by a rise in expenses and sales of cancer drugs Enhertu and Imfinzi were slightly softer than expected, analysts said
AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?
Motley Fool - Mon Jul 22, 9:41AM CDT
Motley Fool
Mon Jul 22, 9:41AM CDT
The big pharma company's top drug is losing ground, but its dividend keeps rising.
1 'Strong Buy' Biotech Stock With 132% Upside Potential
Barchart - Thu Jul 11, 8:49AM CDT
Barchart
Thu Jul 11, 8:49AM CDT
Analysts expect this small-cap biotech stock to more than double in value as it integrates AI into its drug development process.
3 No-Brainer Stocks to Buy for Under $100 Right Now
Motley Fool - Sat Jun 22, 6:15AM CDT
Motley Fool
Sat Jun 22, 6:15AM CDT
You won't need much money to start investing in these great stocks.
Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
GlobeNewswire - Thu Jun 20, 9:00AM CDT
GlobeNewswire
Thu Jun 20, 9:00AM CDT
From Comfort to Cure: 2024 ASCO Meeting Reveals Groundbreaking Oncology Data
Newswire.ca - Wed Jun 19, 12:09PM CDT
Newswire.ca
Wed Jun 19, 12:09PM CDT
/CNW/ -- USA News Group โ This year's 2024 Annual Meeting of the American Society of Clinical Oncology (ASCO) has now come and gone, but not without increasing...